株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界の血糖セルフモニタリング市場

The Global Self-Monitoring of Blood Glucose Market to 2025

発行 GMR Data Ltd 商品コード 322977
出版日 ページ情報 英文 192 Pages
即納可能
価格
本日の銀行送金レート: 1USD=114.77円で換算しております。
Back to Top
世界の血糖セルフモニタリング市場 The Global Self-Monitoring of Blood Glucose Market to 2025
出版日: 2015年01月15日 ページ情報: 英文 192 Pages
概要

当レポートでは、世界の血糖セルフモニタリング(SMBG)市場について調査し、世界・地域・主要国市場の概要、製品セグメント別の分析、主要企業9社のプロファイル、専門家へのインタビュー、および市場のSWOT分析などをまとめ、お届け致します。

第1章 エグゼクティブサマリー

第2章 世界の血糖セルフモニタリング(SMBG)市場

  • 世界のSMBG市場概要
  • 米国市場の概要
  • 欧州市場の概要
  • ドイツ市場の概要
  • フランス市場の概要
  • イタリア市場の概要
  • スペイン市場の概要
  • 英国市場の概要
  • 日本市場の概要
  • 中国市場の概要
  • インド市場の概要
  • ブラジル市場の概要

第3章 グルコース試験紙市場

  • 世界のグルコース試験紙市場
  • 地域のグルコース試験紙市場
  • グルコース試験紙:産業動向
  • 世界のグルコース試験紙&装置市場における促進因子&阻害因子
  • グルコース試験紙、企業および上市ブランド

第4章 血糖測定器市場

  • 血糖測定器
  • 市場における主な血糖測定器
  • 世界&地域の血糖測定器市場
  • 世界の血糖測定器市場における促進因子&阻害因子

第5章 持続血糖測定(CGM)市場

  • 持続血糖測定(CGM)
  • CGMのコンポーネント
  • CGMの範囲
  • 持続血糖測定装置:戦略的パイプライン評価
  • 世界のCGM市場における促進因子&阻害因子
  • 世界&地域のCGM市場

第6章 世界のSMBG市場における主要企業

  • Roche
  • Abbott Laboratories
  • LifeScan (J&J)
  • Johnson & Johnson
  • Bayer Group
  • Arkray Devices
  • Nipro Diagnostics
  • Medtronic Inc.
  • Dexcom

第7章 世界のSMBG市場のSWOT分析

  • 強み
  • 弱み
  • 機会
  • 脅威

第8章 専門家の見解

図表

目次
Product Code: SMBG1

'The Global Self-Monitoring of Blood Glucose Market to 2025' is GMR Data's latest pharma report, covering the pharmaceutical, commercial and strategic developments in the global Self-Monitoring of Blood Glucose (SMBG) market. The report highlights key companies, geographies and products that we believe will deliver strong growth across the next decade.

SMBG is now globally recognised as an integral part of intensive therapy for diabetes; SMBG provides increasingly accurate blood glucose readings which offers significant benefits to diabetics and ultimately, financially, their healthcare providers.

The SMBG market is primarily driven by the growing global diabetic population; a lack of a cure for diabetes; increasing health education among the diabetic population, active reimbursement policies of insurers; the technological advancement aimed at minimal and non-invasive blood glucose testing methods, alongside the availability of blood glucose meters at a nominal cost.

The market for SMBG products has a future simply because of the growing incidence and prevalence of diabetes, increasing spending on healthcare and growing awareness and its implications. However, key challenges remain such as data accuracy, affordability and reimbursement which need to be addressed by the manufacturers, insurance companies and national health authorities.

'The Global Self-Monitoring of Blood Glucose Market to 2025' report includes over 200 tables, charts and graphs quantifying and forecasting the market in detail. In addition, the report offers 9 profiles of the leading companies in the global SMBG market, alongside 4 expert interviewees offering key insights into the state of the market currently and in the future;

  • A Leading Diabetes Care MNC
  • MediWiSe
  • Carewell Biotech
  • Integrity Applications

Table of Contents

1. Executive Summary

  • 1.1 Executive Summary
  • 1.2 Drivers and Restraints of the Global SMBG Market
    • 1.2.1 Drivers
      • 1.2.1.1 Increasing Prevalence and Incidence of Diabetes
      • 1.2.1.2 Insurance / Reimbursement Coverage
      • 1.2.1.3 Increased Access to Health Services & Health Education
      • 1.2.1.4 Technological Innovation
    • 1.2.2 Restraints
      • 1.2.2.1 Generics
      • 1.2.2.2 Emergence of New Technologies Threatening Existing Devices
      • 1.2.2.3 Diverse Regulatory & Reimbursement Policies
  • 1.3 Chapter Breakdown
  • 1.4 Research and Analysis Methods

2. The Global SMBG Market 2015-2025

  • 2.1 Global SMBG Market Overview
    • 2.1.1 Global Diabetes Population
  • 2.2 The US SMBG Market Overview 2015-2025
    • 2.2.1 US SMBG Current Usage & Forecast 2015-2025
    • 2.2.2 US SMBG Market and Forecast 2015-2025
    • 2.2.3 US Blood Glucose Test Strips Market and Forecast 2015-2025
    • 2.2.4 US Blood Glucose Lancet Market and Forecast 2015-2025
    • 2.2.5 US Blood Glucose Meter Market and Forecast 2015-2025
      • 2.2.5.1 The US CGM Market and Forecast 2015-2025
    • 2.2.6 Key factors in the US SMBG market to 2025
      • 2.2.6.1 Reimbursement in the US
      • 2.2.6.2 Increased Spend in Healthcare
      • 2.2.6.3 Increase in Diabetes Prevalence
      • 2.2.6.4 Increased Health Education for Diabetics and Pre-diabetics
      • 2.2.6.5 Product Innovation by manufacturers
      • 2.2.6.6 Robust CGM market
  • 2.3 The European SMBG Market 2015-2025
    • 2.3.1 The European Blood Glucose Test Strips Market and Forecast 2015-2025
    • 2.3.2 The European Blood Glucose Lancet Market and Forecast 2015-2025
    • 2.3.3 The European Blood Glucose Meter Market and Forecast 2015-2025
  • 2.4 The German SMBG Market 2015-2025
    • 2.4.1 German SMBG Current Usage & Forecast 2015-2025
    • 2.4.2 Germany SMBG Market and Forecast 2015-2025
    • 2.4.3 Germany Blood Glucose Test Strips Market and Forecast 2015-2025
    • 2.4.4 Germany Blood Glucose Lancet Market and Forecast 2015-2025
    • 2.4.5 Germany Blood Glucose Meter Market and Forecast 2015-2025
    • 2.4.6 Key factors that will affect the SMBG market in Germany to 2025
      • 2.4.6.1 Reimbursement policy
      • 2.4.6.2 Above Average Spend on Healthcare
      • 2.4.6.3 Increase in Diabetes Prevalence
      • 2.4.6.4 Diabetic Health Education/Awareness
  • 2.5 France SMBG Market 2015-2025
    • 2.5.1 French SMBG Current Usage & Forecast 2015-2025
    • 2.5.2 France SMBG Market and Forecast 2015-2025
    • 2.5.3 France Blood Glucose Test Strips Market and Forecast 2015-2025
    • 2.5.4 France Blood Glucose Lancet Market and Forecast 2015-2025
    • 2.5.5 France Blood Glucose Meter Market and Forecast 2015-2025
    • 2.5.6 Key factors that will affect the SMBG market in France to 2025
      • 2.5.6.1 Reimbursement policy
      • 2.5.6.2 Increased Spend on Healthcare
      • 2.5.6.3 Increase in Diabetes prevalence
  • 2.6 Italy SMBG Market 2015-2025
    • 2.6.1 Italy SMBG Current Usage & Forecast 2015-2025
    • 2.6.2 Italy SMBG Market and Forecast 2015-2025
    • 2.6.3 Italy Blood Glucose Test Strips Market Forecast 2015-2025
    • 2.6.4 Italy Blood Glucose Lancet Market and Forecast 2015-2025
    • 2.6.5. Italy Blood Glucose Meter Market and Forecast 2015-2025
    • 2.6.6 Key factors that will drive the SMBG market in Italy to 2025
      • 2.6.6.1 Reimbursement policy
      • 2.6.6.2 Increased Spend on Healthcare
      • 2.6.6.3 Increase in diabetes prevalence
  • 2.7 Spain SMBG Market 2015-2025
    • 2.7.1 Spain SMBG Current Usage & Forecast 2015-2025
    • 2.7.2 Spain SMBG Market and Forecast 2015-2025
    • 2.7.3 Spain Blood Glucose Test Strips Market and Forecast 2015-2025
    • 2.7.4 Spain Blood Glucose Lancet Market and Forecast 2015-2025
    • 2.7.5 Spain Blood Glucose Meter Market and Forecast 2015-2025
      • 2.7.6.1. Reimbursement policy
      • 2.7.6.2 Increased Spend on Healthcare
      • 2.7.6.3 Increased diabetes prevalence
  • 2.8 The UK SMBG Market 2015-2025
    • 2.8.1 The UK SMBG Current Usage & Forecast 2015-2025
    • 2.8.2 The UK SMBG Market and Forecast 2015-2025
    • 2.8.3 The UK Blood Glucose Test Strips Market and Forecast 2015-2025
    • 2.8.4 The UK Blood Glucose Lancet Market and Forecast 2015-2025
    • 2.8.5 The UK Blood Glucose Meter Market and Forecast 2015-2025
    • 2.8.6 Key factors that will drive the SMBG market in the UK
      • 2.8.6.1 Strong reimbursement policy
      • 2.8.6.2 Increased Spend on Healthcare
      • 2.8.6.3 Increase in diabetes prevalence
  • 2.9 Japan SMBG Market 2015-2025
    • 2.9.1 Japan SMBG Current Usage & Forecast 2015-2025
    • 2.9.2 Japan SMBG Market and Forecast 2015-2025
    • 2.9.3 Japan Blood Glucose Test Strips Market and Forecast 2015-2025
    • 2.9.4 Japan Blood Glucose Lancet Market and Forecast 2015-2025
    • 2.9.5 Japan Blood Glucose Meter Market and Forecast 2015-2025
    • 2.9.6 Key factors that will affect the SMBG market in Japan to 2025
      • 2.9.6.1 Reimbursement in Japan
      • 2.9.6.2 High Spend on Healthcare
      • 2.9.6.3 Increase in Diabetes prevalence
      • 2.9.6.4 Medical Devices/Drugs Approval Times
  • 2.10 China SMBG Market 2015-2025
    • 2.10.1 China SMBG Current Usage & Forecast 2015-2025
    • 2.10.2 China SMBG Market and Forecast 2015-2025
    • 2.10.3 China Blood Glucose Test Strips Market and Forecast 2015-2025
    • 2.10.4 China Blood Glucose Lancet Market and Forecast 2015-2025
    • 2.10.5 China Blood Glucose Meter Market and Forecast 2015-2025
    • 2.10.6 Key factors that will drive the SMBG market in China to 2025
      • 2.10.6.1 Reimbursement in China
      • 2.10.6.2 Significantly Increased Spend in Healthcare
      • 2.10.6.3 Increase in Diabetes prevalence
      • 2.10.6.4 Increased population & unbalanced age distribution
      • 2.10.6.5 Increased Per Capita Disposable Income
  • 2.11 India SMBG Market 2015-2025
    • 2.11.1 India SMBG Current Usage & Forecast 2015-2025
    • 2.11.2 India SMBG Market and Forecast 2015-2025
    • 2.11.3 India Blood Glucose Test Strips Market and Forecast 2015-2025
    • 2.11.4 India Blood Glucose Lancet Market and Forecast 2015-2025
    • 2.11.5 India Blood Glucose Meter Market and Forecast 2015-2025
    • 2.11.6 Key factors that will drive the SMBG market in India
      • 2.11.6.1 Reimbursement in India
      • 2.11.6.2 Governmental Initiatives
      • 2.11.6.3 Increased Spend on Healthcare
      • 2.11.6.4 Increase in Diabetes prevalence
  • 2.12 Brazil SMBG Market 2015-2025
    • 2.12.1 Brazil SMBG Current Usage & Forecast 2015-2025
    • 2.12.2 Brazil SMBG Market and Forecast 2015-2025
    • 2.12.3 Brazil Blood Glucose Test Strips Market and Forecast 2015-2025
    • 2.12.4 Brazil Blood Glucose Lancet Market and Forecast 2015-2025
    • 2.12.5 Brazil Blood Glucose Meter Market and Forecast 2015-2025
    • 2.12.6 Key factors that will drive the SMBG market in Brazil
      • 2.12.6.1 Reimbursement in Brazil
      • 2.12.6.2 Increased Spend on Healthcare
      • 2.12.6.3 Increase in Diabetes prevalence

3. The Glucose Test Strips Market 2015-2025

  • 3.1. The Global Glucose Test Strips Market 2015-2025
  • 3.2. The Regional Glucose Test Strips Market 2015-2025
  • 3.3 Glucose Test Strips: Industry Trends
  • 3.4 Drivers & Restraints in the Global Blood Glucose Strips & Devices Market
    • 3.4.1 Drivers
      • 3.4.1.1 Increasing Global Adoption of Strips
      • 3.4.1.2 Factors Increasing Diabetes Globally
      • 3.4.1.3 Diabetes Awareness Programs & Health Education
    • 3.4.2 Restraints
      • 3.4.2.1 Non-invasive Technology
      • 3.4.2.2 Generic Erosion
      • 3.4.2.2 Product Recalls
  • 3.5 Glucose Test strips, companies and marketed brands

4. The Glucose Meters Market, 2015-2025

  • 4.1. Glucose Meters
    • 4.1.1 Types of Meter
      • 4.1.1.1 Invasive Glucose Meter
      • 4.1.1.2 Non-invasive Glucose Meter
    • 4.1.2 Key Differentials in Glucose Meters
  • 4.2 Key Glucose Meters in the Market
  • 4.3 The Global & Regional Glucose Meter Market 2015-2025
  • 4.4 Drivers & Restraints in the Global Glucose Meter Market to 2025
    • 4.4.1 Drivers
      • 4.4.1.1 High prevalence and increasing incidence of diabetes
      • 4.4.1.2 Growing Health / Diabetes Education
      • 4.4.1.3 Positive reimbursement policies
      • 4.4.1.4 Advancements Meter Functions / Capabilities
    • 4.4.2 Restraints
      • 4.4.2.1 Alternative minimal / non-invasive blood glucose testing methods
      • 4.4.2.2 Continuous Glucose Monitoring
      • 4.4.2.3 Meter Accuracy Issues
      • 4.4.2.4 Meter Recalls

5. The Continuous Glucose Monitoring Market 2015-2025

  • 5.1 Continuous Glucose Monitoring
  • 5.2 CGM Components
  • 5.3 Scope of CGM
  • 5.4 Continuous Glucose Monitoring Systems - Strategic Pipeline Assessment
  • 5.5 Drivers and Restraints of the Global CGM Market
    • 5.5.1 Drivers
      • 5.5.1.1 The Convenience offered by CGM
      • 5.5.1.2 Potential for 'artificial pancreas' or 'closed loop technology'
      • 5.5.1.3 Early detection of Hyper and Hypoglycaemia events by CGM
      • 5.5.1.4 Increasing incidence of diabetes
    • 5.5.2 Restraints
      • 5.5.2.1 Inadequate reimbursement options for CGM
      • 5.5.2.2 Accuracy
      • 5.5.2.3 Small Market Size outside North America
  • 5.6 Global & Regional CGM Market 2015-2025
    • 5.6.1 Global CGM Overview

6. Leading Companies in the Global SMBG Market

  • 6.1 Roche
    • 6.1.1 Roche's Financial Performance
    • 6.1.2 Recent Developments for Roche
  • 6.2 Abbott Laboratories
    • 6.1.1 Abbott's Financial Performance
    • 6.1.2 Recent Developments for Abbott
  • 6.3 LifeScan (J&J)
    • 6.3.1 Recent Developments for LifeScan
  • 6.4 Johnson & Johnson
    • 6.4.1 J&J Financial Performance
    • 6.4.2 Recent Developments
  • 6.5 Bayer Group
    • 6.5.1 Bayer Group Financial Performance
    • 6.5.2 Bayer Group Recent Developments
  • 6.6 Arkray Devices
    • 6.6.1 Recent Developments for Arkray
  • 6.7 Nipro Diagnostics
    • 6.7.1 Nipro Corp Financial Performance
    • 6.7.2 Recent Developments for Nipro
  • 6.8 Medtronic Inc.
    • 6.8.1 Medtronic Inc. Financial Performance
    • 6.8.2 Recent Developments for Medtronic Inc.
  • 6.9 Dexcom
    • 6.9.1 Dexcom's CGM product development landmarks
    • 6.9.2 Dexcom's Financial Performance
    • 6.9.3 Recent Developments for Dexcom

7. SWOT Analysis of the Global SMBG Market 2015-2015

  • 7.1 Strengths
    • 7.1.1 Maturity of Existing SMBG Devices
    • 7.1.2 Reduction in healthcare costs
    • 7.1.3 Global Increase in Diabetics
  • 7.2 Weaknesses
    • 7.2.1 Recording of inaccurate blood glucose levels
    • 7.2.2 Current Low adoption rates of SMBG devices in some geographies
    • 7.2.3 Recurring cost of SMBG devices
  • 7.3 Opportunities
    • 7.3.1 Development of next-generation SMBG devices; Continuous Glucose Monitoring (CGM) & Non-Invasive SMBG Meters
    • 7.3.2 Increased Healthcare Spending Globally
    • 7.3.3 Emerging Markets Offer Untapped Potential
  • 7.4 Threats
    • 7.4.1 Numerous Regulatory & Reimbursement Policies
    • 7.4.2 Increased threat from Generics
    • 7.4.3 Emergence of new technologies threatening existing devices

8. Expert Opinion

  • 8.1 Leading Diabetes Care MNC
  • 8.2 MediWiSe
  • 8.3 Carewell Biotech
  • 8.4 Integrity Applications

Figures

  • Figure 2.1.1 Global SMBG Market Revenue Forecast by region, 2013-2025 ($/bn/%)
  • Figure 2.1.2 Forecast of the Global SMBG Market, 2013-2025 ($/bn)
  • Figure 2.1.3 Breakdown of SMBG market by region, 2013 ($/bn)
  • Figure 2.2.1 Forecast of US SMBG users, 2013-2025 (m)
  • Figure 2.2.2 Forecast of the US SMBG Market, 2013-2025 ($/bn)
  • Figure 2.2.3 Forecast of the US Blood Glucose Test Strips Market, 2013-2025 ($/bn)
  • Figure 2.2.4 Forecast of the US Blood Glucose Lancet Market, 2013-2025 ($/bn)
  • Figure 2.2.5 Forecast of the US Blood Glucose Meter Market, 2013-2025 ($/bn)
  • Figure 2.2.6 CGM market share in the US Market, by supplier 2013 (%)
  • Figure 2.2.7 US Insulin Pump Market 2013 (%)
  • Figure 2.2.8 US Healthcare Spending Per Capita, 2000-2013 ($)
  • Figure 2.3.1 Forecast of the Europe SMBG Market, 2013-2025 ($/bn)
  • Figure 2.3.2 SMBG Market Revenue, by Geography, Europe, 2013 (%)
  • Figure 2.3.3 Forecast of the Europe Blood Glucose Test Strips Market, 2013-2025 ($/bn)
  • Figure 2.3.4 Forecast of the Europe Blood Glucose Lancet Market, 2013-2025 ($/bn)
  • Figure 2.3.5 Forecast of the Europe Blood Glucose Meter Market, 2013-2025 ($/bn)
  • Figure 2.4.1 Forecast of Germany SMBG Users, 2013-2025 (m)
  • Figure 2.4.2 Forecast of the Germany SMBG Market, 2013-2025 ($/bn)
  • Figure 2.4.3 Forecast of the Germany Blood Glucose Test Strips Market, 2013-2025 ($/bn)
  • Figure 2.4.4 Forecast of the Germany Blood Glucose Lancet Market, 2013-2025 ($/bn)
  • Figure 2.4.5 Forecast of the Germany Blood Glucose Meter Market, 2013-2025 ($/bn)
  • Figure 2.5.1 Forecast of France SMBG Users, 2013-2025 (m)
  • Figure 2.5.2 Forecast of the France SMBG Market, 2013-2025 ($/bn)
  • Figure 2.5.3 Forecast of the France Blood Glucose Test Strips Market, 2013-2025 ($/bn)
  • Figure 2.5.4 Forecast of the France Blood Glucose Lancet Market, 2013-2025 ($/m)
  • Figure 2.5.5 Forecast of the France Blood Glucose Meter Market, 2013-2025 ($/bn)
  • Figure 2.6.1 Forecast of Italy SMBG Users, 2013-2025 (m)
  • Figure 2.6.2 Forecast of the Italy SMBG Market, 2013-2025 ($/bn)
  • Figure 2.6.3 Forecast of the Italy Blood Glucose Test Strips Market, 2013-2025 ($/bn)
  • Figure 2.6.4 Forecast of the Italy Blood Glucose Lancet Market, 2013-2025 ($/m)
  • Figure 2.6.5 Forecast of the Europe Blood Glucose Meter Market, 2013-2025 ($/m)
  • Figure 2.7.1 Forecast of Spain SMBG Users, 2013-2025 (m)
  • Figure 2.7.2 Forecast of the Spain SMBG Market, 2013-2025 ($/bn)
  • Figure 2.7.3 Forecast of the Spain Blood Glucose Test Strips Market, 2013-2025 ($/bn)
  • Figure 2.7.4 Forecast of the Spain Blood Glucose Lancet Market, 2013-2025 ($/m)
  • Figure 2.7.5 Forecast of the Spain Blood Glucose Meter Market, 2013-2025 ($/m)
  • Figure 2.7.6 Forecast of the Spain Diabetic Population, 2013-2025 (m)
  • Figure 2.8.1 Forecast of UK SMBG user, 2013-2025 (m)
  • Figure 2.8.2 Forecast of the UK SMBG Market, 2013-2025 ($/bn)
  • Figure 2.8.3 Forecast of the UK Blood Glucose Test Strips Market, 2013-2025 ($/bn)
  • Figure 2.8.4 Forecast of the UK Blood Glucose Lancet Market, 2013-2025 ($/m)
  • Figure 2.8.5 Forecast of the UK Blood Glucose Meter Market, 2013-2025 ($/bn)
  • Figure 2.9.1 Forecast of Japan SMBG Users, 2013-2025 (m)
  • Figure 2.9.2 Forecast of the Japan SMBG Market, 2013-2025 ($/bn)
  • Figure 2.9.3 Forecast of the Japan Blood Glucose Test Strips Market, 2013-2025 ($/bn)
  • Figure 2.9.4 Forecast of the Japan Blood Glucose Lancet Market, 2013-2025 ($/m)
  • Figure 2.9.5 Forecast of the Japan Blood Glucose Meter Market, 2013-2025 ($/m)
  • Figure 2.10.1 Forecast of China SMBG Users, 2013-2025 (m)
  • Figure 2.10.2 Forecast of the China SMBG Market, 2013-2025 ($/m)
  • Figure 2.10.3 Forecast of the China Blood Glucose Test Strips Market, 2013-2025 ($/bn)
  • Figure 2.10.4 Forecast of the China Blood Glucose Lancet Market, 2013-2025 ($/m)
  • Figure 2.10.5 Forecast of the China Blood Glucose Meter Market, 2013-2025 ($/m)
  • Figure 2.10.6 Per Capita Disposable Income, China, 2005-2013 ($)
  • Figure 2.11.1 Forecast of India SMBG Users, 2013-2025 (m)
  • Figure 2.11.2 Forecast of the India SMBG Market, 2013-2025 ($/bn)
  • Figure 2.11.3 Forecast of the India Blood Glucose Test Strips Market, 2013-2025 ($/m)
  • Figure 2.11.4 Forecast of the India Blood Glucose Lancet Market, 2013-2025 ($/m)
  • Figure 2.11.5 Forecast of the India Blood Glucose Meter Market, 2013-2025 ($/m)
  • Figure 2.11.6 Forecast of Public Vs Private Healthcare Spending, India 2005 -2020 ($/bn)
  • Figure 2.11.7 Forecast of India Healthcare Market by Revenues 2015
  • Figure 2.12.1 Forecast of Brazil SMBG Users, 2013-2025 (m)
  • Figure 2.12.2 Forecast of the Brazil SMBG Market, 2013-2025 ($/bn)
  • Figure 2.12.3 Forecast of the Brazil Blood Glucose Test Strips Market, 2013-2025 ($/bn)
  • Figure 2.12.4 Forecast of the Brazil Blood Glucose Lancet Market, 2013-2025 ($/m)
  • Figure 2.12.5 Forecast of the Brazil Blood Glucose Meter Market, 2013-2025 ($/m)
  • Figure 3.2.1 Regional Glucose Test Strips Market Forecast, 2013 and 2025 (%)
  • Figure 3.2.2: Glucose Test Strip Market, by Region, 2013 & 2015 ($/bn)
  • Figure 3.4.1 Top 10 countries ranked by number of Obese people, 2013 (m)
  • Figure 3.4.2: Countries with Leading Obesity Numbers among Adults, 2012
  • Figure 4.4.1 Regional Glucose Meter Market, 2013 and 2025 ($/bn)
  • Figure 4.4.2 Global Glucose Meter Market by Region, 2013 and 2025 (%)
  • Figure 5.6.1 Regional CGM market share, 2013 & 2025 (%)
  • Figure 5.6.2 Worldwide Blood Glucose Monitoring Market, by supplier 2013 (%)
  • Figure 6.1.1: Roche's Diagnostic Segment's sales breakup by business area, 2013
  • Figure 6.2.1: Net sales breakup by business area, Abbott, 2013
  • Figure 6.4.1: J&J Net sales by business, 2013
  • Figure 6.5.1: Bayer Group Net Sales, by Business Sector, 2013
  • Figure 6.5.2 Percentage sales by region, Bayer Group, 2013
  • Figure 6.8.1: Net sales, Medtronic, 2013
  • Figure 6.8.2 Net sales by geography, Medtronic, 2013
  • Figure 7.1 Forecast of Global Diabetic Numbers, Adults, 2013 & 2035 (m)
  • Figure 7.2 Forecast of Diabetes Numbers China & India, 2013 & 2035 (m)

Tables

  • Table 1.1 Drivers and Restraints of the Global SMBG Market
  • Table 1.2 Global Diabetes Population and AGR, 2013-2025 (m, %)
  • Table 2.1 The Global / Regional SMBG Market, 2013-2025 ($/bn)
  • Table 2.2 SMBG market by region, 2013 ($/bn)
  • Table 2.3 Global Diabetes Population, 2013-2025 (m)
  • Table 2.4 Global / Regional Diabetes Population, 2013-2025 (m)
  • Table 2.5 US SMBG Users, 2013 (m)
  • Table 2.6 The US SMBG Market, 2013-2025 ($/bn)
  • Table 2.7 North America SMBG Revenue, 2013 & 2025 ($/bn, %)
  • Table 2.8 The US Blood Glucose Test Strips Market and Forecast, 2013-2025 ($bn)
  • Table 2.9 The US Blood Glucose Lancet Market and Forecast, 2013-2025 ($bn)
  • Table 2.10 The US Blood Glucose Meter Market and Forecast, 2013-2025 ($bn)
  • Table 2.11 Global & US CGM market, 2013-2025 ($/m)
  • Table 2.13 US Blood Glucose Monitors and Test Strip Reimbursement Policy
  • Table 2.14 US CGM Reimbursement Policy
  • Table 2.15 Example of Current Reimbursement Program, for CGM, in the US
  • Table 2.16 US Healthcare Spending Per Capita, 2010-2013 ($, %)
  • Table 2.17 US GDP & Healthcare Spending, 2010-2013 ($/bn)
  • Table 2.18 Diabetes Population, Prevalence and Healthcare Expenditure in the US, 2013
  • Table 2.19 Forecast of the US / Global Adult Diabetic Population, 2013-2025 (m)
  • Table 2.20 Diabetes Prevalence, by Geography, 2013 & 2025 (m, %)
  • Table 2.21 the US Type 1 and Type 2 Diabetes Population, 2013-2025 (m)
  • Table 2.22 Diabetes contribution Type 1 and Type 2, US, 2013 & 2025 (m, %)
  • Table 2.23 Global & US CGM Market 2013-2025 ($/m)
  • Table 2.3.1 The Europe SMBG Market Forecast, 2013-2025 ($/bn)
  • Table 2.3.2 SMBG Revenue, by Geography, Europe, 2013 ($/bn, %)
  • Table 2.3.3 Forecast of the European Blood Glucose Test Strips Market 2013-2025 ($bn)
  • Table 2.3.4 The Europe Blood Glucose Lancet Market and Forecast, 2013-2025 ($/bn)
  • Table 2.3.5 The Europe Blood Glucose Meter Market and Forecast, 2013-2025 ($/bn)
  • Table 2.4.1 Germany SMBG User, 2013 (m)
  • Table 2.4.2 Germany SMBG Market Forecast, 2013-2025 ($/bn)
  • Table 2.4.3 The Germany Blood Glucose Test Strips Market and Forecast, 2013-2025 ($/bn)
  • Table 2.4.4 Germany Blood Glucose Lancet Market and Forecast, 2013-2025 ($/bn)
  • Table 2.4.5 The European and German Blood Glucose Meter Market and Forecast, 2013-2025 ($/bn)
  • Table 2.4.6 German GDP & Healthcare Spending, 2013 ($/bn)
  • Table 2.4.7 Mean healthcare expenditures per person with Diabetes, Europe, 2013 ($)
  • Table 2.4.8 Diabetes Population, Prevalence & Healthcare Expenditure, Germany, 2013 ($)
  • Table 2.4.9 German Diabetes population, 2013-2025 (m)
  • Table 2.4.10 Diabetes Prevalence Germany & Europe (m, %)
  • Table 2.4.11 Germany Diabetes Type 1 and Type 2 population, 2013-2025 (m)
  • Table 2.4.12 Type 1 and Type 2 Diabetes Forecast, Germany 2013 & 2025 (m, %)
  • Table 2.5.1 France SMBG Users, 2013 (m)
  • Table 2.5.2 France SMBG Market Forecast, 2013-2025 ($/bn)
  • Table 2.5.3 France Blood Glucose Test Strips Market and Forecast, 2013-2025 ($/bn)
  • Table 2.5.4 The France Blood Glucose Lancet Market and Forecast, 2013-2025 ($/bn)
  • Table 2.5.5 France Blood Glucose Meter Market and Forecast, 2013-2025 ($/bn)
  • Table 2.5.6 France GDP & Healthcare Spending, 2013 ($/bn)
  • Table 2.5.7 Mean Healthcare Expenditure per person with Diabetes, Europe, 2013
  • Table 2.5.8 Diabetes Population, Prevalence and Healthcare Expenditure in France, 2013 ($)
  • Table 2.5.9 French Diabetic Population Forecast, 2013-2025 (m)
  • Table 2.5.10 Diabetes Total France & Europe, 2013-2025 (m, %)
  • Table 2.5.11 French Type 1 and Type 2 Diabetes Population, 2013-2025 (m)
  • Table 2.5.12 Type 1 and Type 2 Diabetes, France, (m, %)
  • Table 2.6.1 Current Italy SMBG User detail, 2013 (m)
  • Table 2.6.2 The Italy SMBG Market Forecast, 2013-2025 ($/bn)
  • Table 2.6.3 The Italy Blood Glucose Test Strips Market and Forecast, 2013-2025 ($/bn)
  • Table 2.6.4 The Italy Blood Glucose Lancet Market and Forecast, 2013-2025 ($/bn)
  • Table 2.6.5 The Italy Blood Glucose Meter Market and Forecast, 2013-2025 ($/bn)
  • Table 2.6.6 Italy GDP & Healthcare Spending, 2013 ($/bn)
  • Table 2.6.7 Diabetes Population, Prevalence and Healthcare Expenditure in Italy, 2013 ($)
  • Table 2.6.8 The Italian Diabetes Population, 2013-2025 (m)
  • Table 2.6.9 Diabetes Contribution by Geography, Italy (m, %)
  • Table 2.6.10 The Italy Diabetes Type 1 and Type 2 population, 2013-2025 (m)
  • Table 2.6.11 Diabetes Contribution; Type 1 and Type 2, Italy, 2013 & 2025 (m, %)
  • Table 2.7.1 Spain SMBG Users, 2013 (m)
  • Table 2.7.2 Spain SMBG Market, 2013-2025 ($/bn)
  • Table 2.7.3 Spain Blood Glucose Test Strips Market and Forecast, 2013-2025 ($/bn)
  • Table 2.7.4 Spain Blood Glucose Lancet Market and Forecast, 2013-2025 ($/bn)
  • Table 2.7.5 Spain Blood Glucose Meter Market and Forecast 2013-2025 ($/bn)
  • Table 2.7.6 Spain GDP & Healthcare Spending, 2013 ($/bn)
  • Table 2.7.7 Diabetes Population, Prevalence & Healthcare Expenditure, Spain, 2013 ($)
  • Table 2.7.8 The Spain Diabetes Population, 2013-2025 (m)
  • Table 2.7.9 Diabetes Contribution, by Geography, Spain (m, %)
  • Table 2.7.10 The Spain Diabetes Type 1 and Type 2 population, 2013-2025 (m)
  • Table 2.7.11 Diabetes contribution Type 1 and Type 2, Spain (m, %)
  • Table 2.8.1 Current UK SMBG users, 2013 (m)
  • Table 2.8.2 The UK SMBG Market, 2013-2025 ($/bn)
  • Table 2.8.3 SMBG Revenue, by Geography, Europe, 2013 ($/bn, %)
  • Table 2.8.4 The UK Blood Glucose Test Strips Market and Forecast, 2013-2025 ($/bn)
  • Table 2.8.5 The UK Blood Glucose Lancet Market and Forecast, 2013-2025 ($/bn)
  • Table 2.8.6 The UK Blood Glucose Meter Market and Forecast, 2013-2025 ($/bn)
  • Table 2.8.7 UK GDP & Healthcare Spending, 2013 ($/bn)
  • Table 2.8.8 Diabetes Population, Prevalence and Healthcare Expenditure, UK, 2013 ($)
  • Table 2.8.9 The UK Diabetes Population, 2013-2025 (m)
  • Table 2.8.10 Diabetes Contribution, by geography, UK (m, %)
  • Table 2.8.11 Diabetes Prevalence UK, 2013
  • Table 2.8.12 The UK Diabetes Type 1 and Type 2 population, 2013-2025 (m)
  • Table 2.8.13 Diabetes Type 1 and Type 2, UK (m, %)
  • Table 2.9.1 Japan SMBG Users, 2013 (m)
  • Table 2.9.2 The Japan SMBG Market, 2013-2025 ($/bn)
  • Table: 2.9.3 SMBG Revenue, by region, Japan 2013, 2025 ($/bn, %)
  • Table 2.9.4 The Japan Blood Glucose Test Strips Market and Forecast, 2013-2025 ($/bn)
  • Table 2.9.5 The Japan Blood Glucose Lancet Market and Forecast, 2013-2025 ($/bn)
  • Table 2.9.6 The Japan Blood Glucose Meter Market and Forecast, 2013-2025 ($/bn)
  • Table 2.9.7 Japan GDP & Healthcare Spending, 2013 ($/bn)
  • Table 2.9.7 Diabetes Population, Prevalence and Healthcare Expenditure, Japan, 2013 ($)
  • Table 2.9.8 Japan Diabetes Population Forecast, 2013-2025 (m)
  • Table 2.9.9 Diabetes contribution, by geography, Japan (m, %)
  • Table 2.9.10 Japan Diabetes Type 1 and Type 2 population, 2013-2025 (m)
  • Table 2.9.11 Diabetes Type 1 and Type 2, Japan (m, %)
  • Table 2.10.1 China SMBG Users, 2013 (m)
  • Table 2.10.2 The China SMBG Market, 2013-2025 ($/bn)
  • Table 2.10.3 SMBG Revenue, by region, China 2013 & 2025 ($/bn, %)
  • Table 2.10.4 The China Blood Glucose Test Strips Market and Forecast, 2013-2025 ($/bn)
  • Table 2.10.5 The China Blood Glucose Lancet Market and Forecast, 2013-2025 ($/bn)
  • Table 2.10.6 The China Blood Glucose Meter Market and Forecast, 2013-2025 ($/bn)
  • Table 2.10.7 Medical Coverage for Rural / Urban Inhabitants, China, 2006 & 2009 (million people)
  • Table 2.10.8 China GDP & Healthcare Spending, 2013 ($/bn)
  • Table 2.10.9 China per Capita Health Expenditure 2002-2012 ($)
  • Table 2.10.10 Diabetes Population, Prevalence and Healthcare Expenditure China, 2013 ($)
  • Table 2.10.11 China Diabetes Population Forecast, 2013-2025 (m)
  • Table 2.10.12 Diabetes contribution, by Geography, China (m, %)
  • Table 2.10.13 China Diabetes Type 1 and Type 2 population, 2013-2025 (m)
  • Table 2.10.14 Diabetes contribution Type 1 and Type 2, China (m, %)
  • Table 2.10.15 China's Age distribution: 2001 to 2011 (% of total population)
  • Table 2.11.1 India SMBG Users, 2013 (m)
  • Table 2.11.2 The India SMBG Market Forecast, 2013-2025 ($/bn)
  • Table 2.11.3 SMBG Revenue, by region, India 2013 & 2025 ($/bn, %)
  • Table 2.11.4 The India Blood Glucose Test Strips Market and Forecast, 2013-2025 ($/bn)
  • Table 2.11.5 The India Blood Glucose Lancet Market and Forecast, 2013-2025 ($/bn)
  • Table 2.11.6 The India Blood Glucose Meter Market and Forecast, 2013-2025 ($/bn)
  • Table 2.11.7 India GDP & Healthcare Spending, 2013 ($/bn)
  • Table 2.11.8 Forecast of Public Vs Private Healthcare Spending, India 2005 -2020 ($/bn, %)
  • Table 2.11.9 Forecast of India Healthcare Market by Revenues, 2015 ($/bn)
  • Table 2.11.10 Diabetes Population, Prevalence and Healthcare Expenditure, India, 2013 ($)
  • Table 2.11.11 The India Diabetes population, 2013-2025 (m)
  • Table 2.11.12 Diabetes contribution, by Geography, India (m, %)
  • Table 2.11.13 India Type 1 and Type 2 Diabetes Population, 2013-2025 (m)
  • Table 2.11.13 Diabetes contribution Type 1 and Type 2, India (m, %)
  • Table 2.12.1 Current Brazil SMBG Users, 2013 (m)
  • Table 2.12.2 The Brazil SMBG Market 2013-2025 ($/bn)
  • Table 2.12.3 SMBG Revenue, by region, Brazil 2013, 2025 ($/bn, %)
  • Table 2.12.4 The Brazil Blood Glucose Test Strips Market and Forecast, 2013-2025 ($/bn)
  • Table 2.12.5 The Brazil Blood Glucose Lancet Market and Forecast, 2013-2025 ($/bn)
  • Table 2.12.6 The Brazil Blood Glucose Meter Market and Forecast 2013-2025 ($/bn)
  • Table 2.12.7 Brazil GDP & Healthcare Spending, 2013 ($/bn)
  • Table 2.12.8 Diabetes Population, Prevalence and Healthcare Expenditure, Brazil, 2013 ($)
  • Table 2.12.9 The Brazil Diabetes Population, 2013-2025 (m)
  • Table 2.12.10 Diabetes contribution, by Geography, Brazil (m, %)
  • Table 2.12.11 The Brazil Diabetes Type 1 and Type 2 population, 2013-2025 (m)
  • Table 2.12.12 Diabetes contribution Type 1 and Type 2, Brazil (m, %)
  • Table 3.1 Overall SMBG Market Vs Strips 2013-2025 ($/bn)
  • Table 3.2 Glucose Test Strips: Market Forecast, 2013-2025 ($/bn)
  • Table 3.3 Glucose Test Strips Growth, by Region 2013-2025 (%)
  • Table 3.4 Glucose Test Strip Market Occupation, by Region, 2013 & 2025 (%)
  • Table 3.5 Glucose Test Strip Market Occupation, by Region, 2013 & 2025 ($/bn)
Back to Top